Literature DB >> 3337830

Inactivation of rabbit muscle glyceraldehyde-3-phosphate dehydrogenase by koningic acid.

K Sakai1, K Hasumi, A Endo.   

Abstract

Koningic acid, a sesquiterpene antibiotic, is a specific inhibitor of the enzyme glyceraldehyde-3-phosphate dehydrogenase (D-glyceraldehyde-3-phosphate:NAD+ oxidoreductase (phosphorylating), EC 1.2.1.12). In the presence of 3 mM of NAD+, koningic acid irreversibly inactivated the enzyme in a time-dependent manner. The pseudo-first-order rate constant for inactivation (kapp) was dependent on koningic acid concentration in saturate manner, indicating koningic acid and enzyme formed a reversible complex prior to the formation of an inactive, irreversible complex; the inactivation rate (k 3) was 5.5.10(-2) s-1, with a dissociation constant for inactivation (Kinact) of 1.6 microM. The inhibition was competitive against glyceraldehyde 3-phosphate with a Ki of 1.1 microM, where the Km for glyceraldehyde 3-phosphate was 90 microM. Koningic acid inhibition was uncompetitive with respect to NAD+. The presence of NAD+ accelerated the inactivation. In its absence, the charcoal-treated NAD+-free enzyme showed a 220-fold decrease in apparent rate constant for inactivation, indicating that koningic acid sequentially binds to the enzyme next to NAD+. The enzyme, a tetramer, was inactivated when maximum two sulfhydryl groups, possibly cysteine residues at the active sites of the enzyme, were modified by the binding of koningic acid. These observations demonstrate that koningic acid is an active-site-directed inhibitor which reacts predominantly with the NAD+-enzyme complex.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3337830     DOI: 10.1016/0167-4838(88)90130-6

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  14 in total

1.  Responses of hypertrophied myocytes to reactive species: implications for glycolysis and electrophile metabolism.

Authors:  Brian E Sansbury; Daniel W Riggs; Robert E Brainard; Joshua K Salabei; Steven P Jones; Bradford G Hill
Journal:  Biochem J       Date:  2011-04-15       Impact factor: 3.857

2.  Nuclear complex of glyceraldehyde-3-phosphate dehydrogenase and DNA repair enzyme apurinic/apyrimidinic endonuclease I protect smooth muscle cells against oxidant-induced cell death.

Authors:  Xuwei Hou; Patricia Snarski; Yusuke Higashi; Tadashi Yoshida; Alexander Jurkevich; Patrick Delafontaine; Sergiy Sukhanov
Journal:  FASEB J       Date:  2017-04-12       Impact factor: 5.191

3.  Oct1 loss of function induces a coordinate metabolic shift that opposes tumorigenicity.

Authors:  Arvind Shakya; Robert Cooksey; James E Cox; Victoria Wang; Donald A McClain; Dean Tantin
Journal:  Nat Cell Biol       Date:  2009-02-15       Impact factor: 28.824

4.  A Predictive Model for Selective Targeting of the Warburg Effect through GAPDH Inhibition with a Natural Product.

Authors:  Maria V Liberti; Ziwei Dai; Suzanne E Wardell; Joshua A Baccile; Xiaojing Liu; Xia Gao; Robert Baldi; Mahya Mehrmohamadi; Marc O Johnson; Neel S Madhukar; Alexander A Shestov; Iok I Christine Chio; Olivier Elemento; Jeffrey C Rathmell; Frank C Schroeder; Donald P McDonnell; Jason W Locasale
Journal:  Cell Metab       Date:  2017-09-14       Impact factor: 27.287

5.  Evolved resistance to partial GAPDH inhibition results in loss of the Warburg effect and in a different state of glycolysis.

Authors:  Maria V Liberti; Annamarie E Allen; Vijyendra Ramesh; Ziwei Dai; Katherine R Singleton; Zufeng Guo; Jun O Liu; Kris C Wood; Jason W Locasale
Journal:  J Biol Chem       Date:  2019-11-20       Impact factor: 5.157

Review 6.  Anticancer agents that counteract tumor glycolysis.

Authors:  Carlotta Granchi; Filippo Minutolo
Journal:  ChemMedChem       Date:  2012-06-08       Impact factor: 3.466

7.  Assessing bioenergetic function in response to oxidative stress by metabolic profiling.

Authors:  Brian P Dranka; Gloria A Benavides; Anne R Diers; Samantha Giordano; Blake R Zelickson; Colin Reily; Luyun Zou; John C Chatham; Bradford G Hill; Jianhua Zhang; Aimee Landar; Victor M Darley-Usmar
Journal:  Free Radic Biol Med       Date:  2011-08-16       Impact factor: 7.376

8.  Nitric oxide-dependent NAD linkage to glyceraldehyde-3-phosphate dehydrogenase: possible involvement of a cysteine thiyl radical intermediate.

Authors:  M Minetti; D Pietraforte; A M Di Stasi; C Mallozzi
Journal:  Biochem J       Date:  1996-10-15       Impact factor: 3.857

9.  Pentalenolactone-insensitive glyceraldehyde-3-phosphate dehydrogenase from Streptomyces arenae is closely related to GAPDH from thermostable eubacteria and plant chloroplasts.

Authors:  K U Fröhlich; R Kannwischer; M Rüdiger; D Mecke
Journal:  Arch Microbiol       Date:  1996-03       Impact factor: 2.552

10.  Glyceraldehyde-3-phosphate dehydrogenase is required for the transport of nitric oxide in platelets.

Authors:  B McDonald; B Reep; E G Lapetina; L Molina y Vedia
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.